Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.
Jonas
Jost B
JB
Universitäts-Augenklinik, Mannheim, Germany. jost.jonas@ma.augen.uni-heidelberg.de
Kreissig
Ingrid
I
Degenring
Robert
R
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005122:Exudates and Transudates; D005260:Female; D005902:Glaucoma, Open-Angle / Q000139:chemically induced* / Q000188:drug therapy; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects; D015861:Retinal Neovascularization / Q000188:drug therapy; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
D000959:Antihypertensive Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide